SCHEMBL2912228

SCHEMBL2912228

CCOC(=O)c1nc(N)c2[nH]c(=O)n(Cc3ccccc3)c2n1

nearest known ligand 0.70

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 20/20 0.70
NUDT1 P36639 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3134131 0.89 TLR7 (0.76) TLR7NUDT1
SCHEMBL3133950 0.85 TLR7 (0.77) TLR7NUDT1
SCHEMBL3146807 0.84 TLR7 (0.75) TLR7NUDT1
SCHEMBL3141800 0.83 TLR7 (0.80) TLR7NUDT1
SCHEMBL3139086 0.82 TLR7 (1.00) TLR7NUDT1
SCHEMBL3137353 0.81 TLR7 (0.65) TLR7NUDT1
SCHEMBL3137361 0.81 TLR7 (0.65) TLR7NUDT1
SCHEMBL16206181 0.80 TLR7 (1.00) TLR7NUDT1
Urethane SCHEMBL3128318 0.80 TLR7 (0.64) TLR7NUDT1
SCHEMBL18221128 0.79 TLR7 (1.00) TLR7NUDT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8372836-B2 Spray dried formulation BEND RESEARCH, INC. (US) 2013-02-12 US disclosed
US-8372836-B2 Spray dried formulation BEND RESEARCH, INC. (US) 2013-02-12 US disclosed
US-8372836-B2 Spray dried formulation BEND RESEARCH, INC. (US) 2013-02-12 US disclosed
EP-2101741-B1 SOLID DISPERSION COMPRISING A POORLY WATER SOLUBLE DRUG BEND RES INC (US) 2010-08-11 EP disclosed
EP-2101741-B1 SOLID DISPERSION COMPRISING A POORLY WATER SOLUBLE DRUG BEND RES INC (US) 2010-08-11 EP disclosed
US-20100029667-A1 Spray dried formulation BEND RESEARCH INC. 2010-02-04 US disclosed
US-20100029667-A1 Spray dried formulation BEND RESEARCH INC. 2010-02-04 US disclosed
US-20100029667-A1 Spray dried formulation BEND RESEARCH INC. 2010-02-04 US disclosed
US-7642350-B2 Purine derivatives PFIZER LIMITED (GB) 2010-01-05 US disclosed
US-7642350-B2 Purine derivatives PFIZER LIMITED (GB) 2010-01-05 US disclosed
US-7642350-B2 Purine derivatives PFIZER LIMITED (GB) 2010-01-05 US disclosed
EP-2101741-A2 SOLID DISPERSION COMPRISING A POORLY WATER SOLUBLE DRUG BEND RESEARCH, INC. (US) 2009-09-23 EP disclosed
WO-2008047201-A2 SOLID DISPERSION COMPRISING A POORLY WATER SOLUBLE DRUG PFIZER PRODUCTS INC. (US) 2008-04-24 WO disclosed
WO-2008047201-A2 SOLID DISPERSION COMPRISING A POORLY WATER SOLUBLE DRUG PFIZER PRODUCTS INC. (US) 2008-04-24 WO disclosed
US-20060264448-A1 Purine derivatives PFIZER LIMITED 2006-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029667-A1 Spray dried formulation PRKG1, PDE7A, PDE10A TLR7 2925/4885NUDT1 2522/4885
US-20060264448-A1 Purine derivatives TLR9, TLR7, TLR1 TLR7 2/4885NUDT1 42/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.